Page 10 - Repligen Corp News Today

Wall Street brokerages expect that Repligen Co. (NASDAQ:RGEN – Get Rating) will post $183.55 million in sales for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Repligen’s earnings, with the lowest sales estimate coming in at $171.50 million and the highest estimate coming in at $193.21 million. Repligen posted […]

Wall Street analysts expect that Repligen Co. (NASDAQ:RGEN – Get Rating) will announce earnings per share (EPS) of $0.72 for the current quarter, Zacks Investment Research reports. Six analysts have provided estimates for Repligen’s earnings, with the highest EPS estimate coming in at $0.76 and the lowest estimate coming in at $0.66. Repligen posted earnings […]

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

IFP Advisors Inc decreased its holdings in Repligen Co. (NASDAQ:RGEN – Get Rating) by 91.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 126 shares of the biotechnology company’s stock after selling 1,398 shares during the quarter. IFP Advisors Inc’s holdings in Repligen were worth $35,000 at the end of the most recent reporting […]

LRT Capital Management LLC purchased a new stake in Repligen Co. (NASDAQ:RGEN – Get Rating) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 16,710 shares of the biotechnology company’s stock, valued at approximately $4,425,000. Repligen makes up approximately 3.4% of LRT Capital Management LLC’s holdings, making the stock its 9th biggest holding. […]

/PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled...

/PRNewswire/ -- The Life Science and Chemical Instrumentation Market Share is expected to increase by USD 14.94 billion from 2021 to 2026, at an accelerated...

WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Thursday reported fourth-quarter earnings...

WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Thursday reported fourth-quarter earnings of $29.1 million.

Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.